Phospholipid hydroperoxide glutathione peroxidase (PHGPx), a selenium-dependent glutathione peroxidase, can interact with lipophilic substrates, including the phospholipid hydroperoxides, fatty-acid hydroperoxides, and cholesteryl ester hydroperoxides, and reduce them to hydroxide compounds. We studied the functional role of endogenous PHGPx in regulation of 12(S)-lipoxygenase and cyclooxygenase 1 activities in human epidermoid carcinoma A431 cells by using a cell system overexpressing anti-PHGPx mRNA. A retroviral expression vector designated as L1-3, wherein cDNA of PHGPx was reversely inserted into pFB-ERV in antisense orientation, was constructed. A number of stable transfectants of A431 cells with PHGPx depletion were generated from virions containing plasmid L1-3. In an intact cell assay system, the metabolism of arachidonic acid to prostaglandin E 2 and 12(S)-hydroxyeicosatetraenoic acid was significantly enhanced in stable L1-3 transfectants compared with that in vector-control cells. Flow cytometric analysis revealed a significant elevated level of intracellular hydroperoxides in stable L1-3 transfectants. Treatment of stable L1-3 transfectants with 50 µM arsenite induced more significant formation of intracellular hydroperoxides than that of vector-control cells. Taken together, these results support the notion that the endogenous PHGPx plays a pivotal role in the regulation of 12(S)-lipoxygenase and cyclooxygenase 1 activities by reducing the level of intracellular lipid hydroperoxides in arachidonate metabolism in A431 cells.
ipoxygenases and fatty acid cyclooxygenase are the major enzymes of metabolizing polyunsaturated fatty acids such as arachidonic acid (1) . Arachidonic acid is metabolized to 5-, 12-, and 15-hydroperoxyeicosatetraenoic acids (HPETEs) by 5-, 12-, and 15-lipoxygenases, respectively. The HPETEs belong to one group of reactive oxygen species and are metabolized to hydroxide compounds usually by a glutathione-dependent peroxidase system (2) . Presence of 12(S)-lipoxygenase was identified in human epidermoid carcinoma A431 cells (3) . Arachidonic acid is also metabolized to prostaglandin (PG) endoperoxide G 2 by cyclooxygenase, followed by the reduction to PG H 2 . L Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a selenium-dependent member of a family consisting of five isozymes: a) classical cellular GPx1 (4), b) PHGPx (5), c) plasma GPx-P (6), d) gastrointestinal, GPx-GI (7) , and e) epididymal . Among these isozymes, PHGPx is unique in the substrate specificity because it can interact with lipophilic substrates, including the phospholipid hydroperoxides, fatty acid hydroperoxides, and cholesteryl ester hydroperoxides, and reduce them to hydroxide compounds (9) (10) (11) .
In an early study of the regulation of arachidonate metabolism in human epidermoid carcinoma A431 cells, we reported a putative inhibitor of 12(S)-lipoxygenase in cells (12) . It was purified to a 22 kDa protein whose inhibitory activity was regulated by the cellular reduction-oxidation (redox) reaction (13) . The purified inhibitor protein was identified as PHGPx by a high-sensitivity microsequencer and mass spectrometer (14) . In a cell-free assay using purified human 12(S)-lipoxygenase and cyclooxygenase, PHGPx inhibited the activity of both enzymes (15) . To explore the functional role of endogenous PHGPx in arachidonate metabolism in cells, we previously found that depletion of GSH by treatment of cells with diethyl maleate resulted in up-regulation of the enzyme activities of 12(S)-lipoxygenase and cyclooxygenase (16) . However, this evidence was indirect because GSH depletion in cells could not exactly distinguish the activity of PHGPx from that of GPx1. Therefore, in this study, we established a stable cell line that overexpressed anti-PHGPx mRNA to specifically block the formation of endogenous PHGPx in cells. By using these antisense stable transfectants, we studied the functional role of endogenous PHGPx in the regulation of 12(S)-lipoxygenase and cyclooxygenase 1 activities in cells. This is the first report of the use of a stable cell line with depletion of PHGPx to study the functional role of endogenous PHGPx in cells.
MATERIALS AND METHODS

Materials
Plasmids of pFB-ERV and pOPRSVI/ MCS and MBS Mammalian Transfection kit were obtained from Stratagene (La Jolla, CA). Plasmids of pcDNA3.1/His and pcDNA3.1/His-lacZ were obtained from Invitrogen (Groningen, The Netherlands). Plasmid pSVlacO was obtained from H.-S. Liu (National Cheng Kung University, Taiwan). [1- 14 C]Arachidonic acid (55.0 mCi/mmol) was purchased from Amersham Biosciences (Bucks, U.K.). Silica gel 60 TLC plate (0.25 mm thick) was from E. Merck AG (Darmstadt, Germany). Bovine serum albumin, indomethacin, 2',7'-dichlorofluorescin diacetate (DCFH-DA), chloroquine, and polybrene were from Sigma (St. Louis, MO). NS398 was obtained from BIOMOL (Plymouth Meeting, PA). Monoclonal antibody against cyclooxygenase 1 was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antibody against GPx1 was obtained from MBL (Nagoya, Japan). Antibody against 12-lipoxygenase was from Oxford Biomedical Research (Oxford, MI). Dulbecco's modified Eagle Medium (DMEM) was obtained from Gibco BRL (Grand Island, NY). Fetal bovine serum (FBS) was from Hyclone Laboratories (Logan, UT).
Cell culture
Human epidermoid carcinoma A431 cells and Amphopack-293 cells (Clontech, Palo Alto, CA) were grown at 37°C under air/CO 2 (19:1) in 10 cm plastic dishes containing 8 ml of culture medium consisting of DMEM supplemented with 10% (v/v) FBS, 100 µg/ml streptomycin, and 100 U/ml penicillin.
RNA preparation and RT-PCR
Total RNA preparation was performed by the Ultraspec TM -II RNA isolation system (Biotecx Laboratories, Houston, TX). Briefly, cells were washed twice with PBS and scraped with a Teflon policeman in 1 ml of Ultraspec® RNA per 10 cm Petri dish. After extraction with 0.2 ml of chloroform, the total RNA was purified by Tack TM resin (Biotecx). The resin pellet was washed twice with 1 ml of 75% ethanol and subsequently dried. The total RNA was eluted with 100 µl of DEPC-treated water, and the RNA content was determined by measuring the absorbance at OD 260 nm. The RT-PCR was performed in a Gene Amp PCR System model 2400 (PE Applied Biosystems, Foster City, CA). The first RT-PCR cycle consisted of Superscript II (Invitrogen) at 40°C for 50 min and denaturing at 95°C for 5 min, 30 cycles of denaturing at 95°C for 30 s, annealing at 50°C for 30 s, and elongation at 72°C for 1 min, and an additional elongation at 72°C for 5 min. The following forward and reverse primers (respectively) were used for PCR amplification:
His-tag anti-PHGPx mRNA, 5′-AACGTCGTGACTGGGAAAAC-3′, 5′-CACCAAGTTCCTCATCGACA-3′ (700 bp); β-actin, 5′-CCTAAGGCCAACCGTGAAAAG-3′, 5′-TCTTCATGGTGCTAGGAGCCA-3′ (620 bp).
Construction of anti-PHGPx mRNA expression vectors
To reversely clone PHGPx cDNA into pcDNA3.1/His, the latter was digested with BamHI and then blunted. The PHGPx cDNA, prepared as in the previous report (17) , was cloned into modified pcDNA3.1/His. The plasmid product was designated as C2. To truncate the 3′-end region of lacZ, pcDNA3.1/His-lacZ was digested with Hind III and EcoRV. The His-tag of lacZ with its 5′-end region was amplified with Pfu polymerase by using 5′-TAAACTTAAGCTTACCATGG-3′ (forward) and 5′-ATCACAGATGAAACGCCGAGTT-3′ (reverse) as primers and pcDNA3.1/His-lacZ as a template. The resulting PCR fragment was treated with Hind III and cloned into modified pcDNA3.1/His-lacZ. The plasmid product was designated as N1. To clone the His-tag of lacZ with its 5′-end region into pSVlacO, the latter was digested with Pst I and Sac I. The His-tag of lacZ with its 5′-end region was amplified with Pfu polymerase by using 5′-AAACTGCAGAAACTTAAGCTTACCATGGG-3′
(forward) and 5′-ACCGAGCTCTTTCCGCCTCAGAAGCCA-3′ (reverse) as primers and N1 as a template. The resulting PCR fragment was treated with Pst I/ Sac I and cloned into modified pSVlacO. The plasmid product was designated as N1-1. To clone the His-tag of lacZ with its 5′-end region into pOPRSVI/ MCS, the latter was digested with EcoRV and Xba I. Plasmid N1-1 was treated with Pst I/Klenow/Xba I and cloned into modified pOPRSVI/MCS. The plasmid product was designated as I7. To clone reversely the PHGPx cDNA into I7, the latter was digested with EcoRV and Xba I. Plasmid C2 was treated with Sfo I/Xba I and cloned into modified I7. The plasmid product was designated as K10. To clone the His-tag of lacZ containing its 5′-end region and reversely the PHGPx cDNA into pFB-ERV, the latter was digested with Fse I, blunted, and digested with Not I. Plasmid K10 was treated with Xho I/ klenow/Not I and cloned into modified pFB-ERV. The plasmid product was designated as L1-3. All of the construct plasmids were verified by DNA sequencing.
Establishment of stable virion-producing cell lines
Transfection was performed with MBS Mammalian Transfection kit according to the manufacturer's instructions. Amphopack-293 cells were replated 24 h before transfection at a density of 6 × 10 5 cells in 2.5 ml of fresh culture medium in a 6 cm plastic dish. For transfection, cells were pre-incubated with 4 ml of culture medium consisting of DMEM supplemented with 6% (v/v) modified serum (solution 3) for 30 min in CO 2 incubator. The DNA mixture (1 ml), containing 3 µg of plasmid, 50 µl of solution 1, and 500 µl of solution 2, was stood for 10 min at room temperature. Cells were transfected by joining the DNA mixture containing 25 µM chloroquine and then were incubated in a CO 2 incubator for 24 h. After replacing the medium with 2.5 ml of fresh culture medium, cells were incubated for an additional 24 h. Selection was performed with 300 µg/ml G418 dissolved in DMEM containing 10% FBS. After 20 days, individual resistant clones were selected and expanded. Stable transfectants of Amphopack-293 cells were cultured with fresh G418(-) medium for 24 h, and the condition medium was used for infection of A431 cells.
Establishment of antisense stable cell clones
Stable cell clones with anti-PHGPx mRNA was produced by transfection of A431 cells with virions produced by Amphopack-293 cells. A431 cells were replated 18 h before infection at a density of 3 × 10 5 cells in 2 ml of fresh culture medium in a 3.5 cm plastic dish. A431 cells were infected by changing the medium with the condition medium of Amphopack-293 cells containing 8 µg/ml of polybrene and then were incubated for 24 h. After changing medium with fresh DMEM containing 10% FBS, we continuously incubated the cells for 24 h. Selection was performed with 300 µg/ml G418 dissolved in DMEM containing 10% FBS. After 20 days, individual resistant clones were selected and expanded.
Preparation of cell lysate
Cells in a 6 cm Petri dish were washed twice with PBS and lysed in 150 µl of lysis reagent (150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 1 mM GSH, 1% IGEPAL CA630, 0.5% sodium deoxycholate, and 50 mM Tris-HCl, pH 7.5). After a 20-min incubation at 4°C, the lysate was centrifuged at 7200 g for 5 min and the supernatant solution was used as the cell lysate. Protein content of cell lysates was determined by the method of Lowry et al. (18) with bovine serum albumin as a standard.
Western blotting
The cell lysate was separated by reducing SDS-PAGE using 12% slab gels with a 30 mA operation voltage for 50 min. Proteins separated on the gel were immediately transferred to a PVDF membrane by an electroblot apparatus. An antibody against human PHGPx (17) was used as the primary antibody. Immunblot analysis was performed with rabbit IgG antibody coupled to horseradish peroxidase. An enhanced chemiluminescence kit (Amersham) was used for detection.
Intact cell assay of arachidonate metabolism
Confluent cells grown in six-multiwell dishes were washed twice with HEPES buffer (137 mM NaCl, 1.26 mM CaCl 2 , 5.36 mM KCl, 0.49 mM MgCl 2 , 22 mM HEPES, 0.44 mM KH 2 PO 4 , 0.41 mM MgSO 4 , and 0.34 mM Na 2 HPO 4 , pH 7.4), followed by incubation with 1 ml of HEPES buffer containing 0.25 µCi of [1- 14 C] arachidonic acid, 3.75 µg of arachidonic acid, and 10 µM calcium ionophore A23187 at 37°C for 30 min. The reaction medium was acidified to pH 3.0 with 1 N HCl and extracted with 1 ml of ethyl acetate. Formation of arachidonate metabolites was analyzed by thin-layer chromatography. The plates were developed in the organic phase of a solvent system of ethyl acetate/2,2,4-trimethylpentane/acetic-acid/water (11:5:2:10, by vol.). Product formation was determined by a System 2000 Imaging Scanner (BIOSCAN).
Flow cytometric analysis of intracellular hydroperoxides
To assess levels of intracellular lipid hydroperoxides, we performed flow cytometric analysis by using DCFH-DA, an oxidation-sensitive fluorescent probe. Cells were washed with PBS and incubated with 100 µM DCFH-DA for 1 h. DCFH-DA was deacylated to a nonfluorescent compound 2',7'-dichlorofluorescein (DCFH) within the cells, and DCFH was oxidized to the fluorescent compound 2',7'-dichlorofluorescein by a variety of hydroperoxides (19) . The fluorescent intensity of dichlorofluorescein (DCF) in the cells was analyzed with a fluorescence-activated cell sorter (FACScan, Becton Dickinson, Mountain View, CA).
RESULTS
Arachidonate metabolism in anti-PHGPx mRNA transfectants
Expression vectors of L1-3 and pFB-ERV as shown in Fig. 1 were used to transfect Amphopack-293 cells to produce anti-PHGPx mRNA and vector-control virions, respectively. Stable cell line ANR-10 of Amphopack-293 cells, which could produce high-titer of anti-PHGPx mRNA, was established. A control cell line AER-18, which produced vector-control virions, was also produced. By using antisense virions produced by ANR-10 cell line for infection of A431 cells, we generated several stable clones, including NR8 and NR101. A vector-control transfectant NER4 was also generated by using vector-control virions produced by AER-18 cell line for infection of A431 cells. Expression of PHGPx antisense mRNA in these transfectants was detected by RT-PCR analysis using specific primers designed for His-tag antisense-PHGPx mRNA. As shown in Fig. 2 , His-tag antisense-PHGPx mRNA expressed in anti-PHGPx mRNA transfectants but not in vector-control transfectant. The immunoblot analysis confirmed that PHGPx was almost depleted in anti-PHGPx mRNA transfectants but not in vector-control transfectant (Fig. 3a) , and no significant change of GPx1 expression was observed in anti-PHGPx mRNA transfectants (Fig.  3b) . The functional role of PHGPx in arachidonate metabolism in cells was then studied. As shown in Fig. 3c , in an intact cell assay, the metabolism of arachidonic acid to 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) and PG E 2 significantly increased in anti-PHGPx mRNA transfectants, compared with that of vector-control transfectant. PG E 2 production in cells was due to the metabolism of arachidonic acid by cyclooxygenase 1 because PG E 2 formation was inhibited by indomethacin but not by the specific cyclooxygenase 2 inhibitor NS398 (data not shown). The expression of 12(S)-lipoxygenase and cyclooxygenase 1 in these transfectants did not change (Fig. 3a) . Therefore, these results conclude that the low expression of PHGPx resulted in an elevated level of arachidonate metabolites through the enhancement of enzyme activity expression of 12(S)-lipoxygenase and cyclooxygenase 1 in anti-PHGPx mRNA transfectants.
Formation of intracellular hydroperoxides in stable transfectants
Because many reports indicate that lipoxygenases and cyclooxygenases need a certain "peroxide tone" for the initial reaction of arachidonate catabolism (20, 21) , the intracellular level of hydroperoxides in these transfectants was determined by a flow cytometric analysis using DCFH-DA as a fluorescent probe. As shown in Fig. 4 , the basal fluorescence intensity of DCF in anti-PHGPx mRNA transfectants was significantly higher than that observed in the vector-control transfectant. We reported recently that treatment of A431 cells with arsenite fostered the intracellular formation of hydroperoxides (22) . The effect of the depletion of endogenous PHGPx on arsenite-induced formation of intracellular hydroperoxides was then studied. As shown in Fig.  5 , the increase in fluorescence intensity in anti-PHGPx mRNA transfectants was significantly higher than that in vector-control transfectant upon arsenite treatment. These results support the notion that the endogenous PHGPx plays a functional role in the regulation of hydroperoxides in cells.
DISCUSSION
In the series of studies on the regulation of arachidonate metabolism by PHGPx in cells, the direct evidence to ascertain the functional role of endogenous PHGPx in the regulation of arachidonate metabolism has not been provided yet. So far, there are several reports of using the approach of PHGPx overexpression to study this notion. Overexpression of PHGPx in RBL-2H3 cells suppressed the leukotriene formation through 5-lipoxygenase (23), and also attenuated the activation of cyclooxygenase 2 (24) . We also recently reported that overexpression of PHGPx in A431 cells attenuated the 12-lipoxygenase and cyclooxygenase 1 activities (17) . Although results of these three reports agree well that PHGPx overexpression in cells could attenuate the arachidonate metabolism, these results are still not enough to directly indicate the functional role of endogenous PHGPx in arachidonate metabolism in cells. Therefore, in this study, we established a stable cell line with deletion of PHGPx by an antisense approach. This is the first report to use a stable cell line with PHGPx depletion to answer the notion about the functional role of endogenous PHGPx in cells. Our results strongly suggest that depletion of endogenous PHGPx in A431 cells enhances not only the 12(S)-lipoxygenase activity, but also the cyclooxygenase 1 activity. These results provide the direct evidence for the participation of the endogenous PHGPx in the regulation of arachidonate metabolism through 12(S)-lipoxygenase and cyclooxygenase 1. Taken together, the results of PHGPx overexpression and the present antisense study lead to the conclusion that level of the endogenous PHGPx indeed plays a pivotal role in regulating the arachidonate metabolism in cells.
Both of PHGPx and GPx1 are involved in reducing hydroperoxides in cells. We previously found that the ratio of PHGPx and GPx1 enzyme activities in A431 cells and human platelets was 2.1 and 0.2, respectively, and the enzyme activity of PHGPx in A431 cells was 4.6 fold higher than that in human platelets (16) . Higher presence of PHGPx at the protein level in A431 cells than human platelets was then confirmed (25). Ho et al. (26) reported that platelets from GPx1-deficient mice incubated with arachidonic acid generated less 12(S)-HETE and more polar products, presumably 12(S)-HPETE decomposition products due to a decreased ability to reduce the 12(S)-HPETE intermediate. In PHGPx-depleted A431 cells, the expression of GPx1 was not altered as shown in Fig. 3b . 12(S)-HETE was found to be the major product of 12(S)-lipoxygenase, and no formation of polar products due to 12(S)-HPETE decomposition was observed in our assay system. Taken together, these results clearly indicated that GPx1 plays a major functional role in reducing 12(S)-HPETE to 12(S)-HETE, and PHGPx could regulate the expression of 12(S)-lipoxygenase enzyme activity in A431 cells and human platelets.
In cells used in the present study, only cyclooxygenase 1 but no cyclooxygenase 2 was expressed. Our results clearly indicate that expression of cyclooxygenase 1 activity was down-regulated by PHGPx in A431 cells. Cyclooxygenase 2 is induced in A431 cells treated with epidermal growth factor (EGF) (27) , and we previously found that ~3.5-fold increase in PG E 2 production in EGF-treated A431 cells, compared with control cells, was observed (12) . These results suggested that cyclooxygenase 2 induced by EGF was regulated by the intracellular PHGPx only to a limited extent in A431 cells.
Prior to structural identification of the cytosolic inhibitor of arachidonate metabolism as PHGPx, the putative inhibitor is also observed in the primary culture of ovine tracheal epithelial cells (28) in addition to A431 cells (12) . The activity of putative inhibitor in inhibiting arachidonate metabolism in ovine tracheal epithelial is attenuated by the supplementation of lipid hydroperoxides in cell culture medium, indicating that the inhibitor activity depends on the changes in cellular oxidation-reduction conditions (28) . In studying the arachidonate metabolism, many reports indicate that lipoxygenases and cyclooxygenases need a certain peroxide tone for their enzyme activities (20, 21) . PHGPx is one of glutathione peroxidase and can reduce peroxides, including phospholipid hydroperoxides and other lipid hydroperoxides. Therefore, it is reasonable to deduce that PHGPx is an inhibitor of arachidonate metabolism and that it attenuates the peroxides tone, a step required for the activities of cyclooxygenases and 12(S)-lipoxygenase, which results in the attenuation of arachidonate metabolism in cells. Our present study has also provided another piece of evidence to support this reasoning. Depletion of the endogenous PHGPx enhanced the basal level of cellular hydroperoxides (Fig. 4) ; accumulation of cellular hydroperoxides upon arsenite treatment was more significant in PHGPx-depleted cells than that in vector-control cells (Fig. 5) . These results clearly indicate that the endogenous PHGPx could play a functional role in reducing peroxides tone.
In addition to the functional role in the regulation of arachidonate metabolism, it was also reported that PHGPx might participate in the regulation of cell apoptosis. A relationship between the reactive oxygen species and apoptosis has been well defined (29) . Many pro-oxidant agents, such as hydrogen peroxide and etoposide, induce cell apoptosis (30, 31) , and some apoptotic stimuli, such as treatment with tumor necrosis factor-α and ceramide, induce apoptosis through the mediation of intracellular formation of reactive oxygen species (32, 33) . Overexpression of mitochondrial PHGPx in RBL2H3 cells indeed suppresses cell apoptosis induced by 2-deoxyglucose treatment (34) . Our laboratory also recently found that overexpression of PHGPx in A431 cells attenuated cell apoptosis induced by arsenite treatment (22) . Using the stable cell line with deletion of PHGPx, we observed that these cells were more sensitive to arsenite treatment than vector-control cells in inducing apoptosis (Chen, C. J. et al., unpublished results), further supporting the functional role of endogenous PHGPx in apoptosis mediated by the reactive peroxides. Therefore, the PHGPx-depleted transfectants will be a good cell model to study the underlying mechanism of cell growth control mediated by the intracellular peroxides tone. + mRNA (3 µg) from these transfectants (1. vector-control; 2. 3. anti-PHGPx mRNA transfectants) were reverse-transcribed and amplified with either tag-anti-PHGPx mRNA-specific primers or β-actin specific primers (as an internal control). The PCR products were then electrophoresed on a 1% agarose gel and stained with ethidium bromide. 
HETE in transfectants. a)
The total cell lysates of these transfectants were prepared as described in Materials and Methods. Protein (50 µg) were loaded and analyzed by Western blotting using anti-PHGPx, 12(S)-lipoxygenase (12(S)-LOX), cyclooxygenase 1 (COX 1), and β-actin polyclonal antibody to detect PHGPx, 12(S)-lipoxygenase, cyclooxygenase 1, and β-actin, respectively. b) Protein of cell lysates (50 µg) were loaded and analyzed by Western blotting using anti-GPx1 monoclonal and β-actin polyclonal antibodies to detect GPx1 and β-actin, respectively. c) Confluent cells in 12-multiwell plastic dishes were incubated with 2.5 µg of [1-14 C] arachidonic acid (0.125 µCi) and 10 µM calcium ionophore A23187 in 0.5 ml of HEPES buffer for 30 min. Formations of PG E 2 and 12(S)-HETE in buffer were then analyzed by thin-layer chromatographic analysis. Each value represents the mean ± SE from triplicate assays. * *P < 0.01; *P < 0.05. To assess levels of intracellular peroxides, flow cytometric analysis was performed with the fluorescent probe DCFH-DA. Vector-control transfectant (NER4) and anti-PHGPx mRNA transfectants (NR8 and NR101) were preincubated with 50 µM arsenite for 1 h at 37°C and then incubated with 100 µM DCFH-DA for 1 h. The intensity of fluorescence of DCF in cells was quantified by flow cytometry.
